Aihe-ehdotuksia
Aihe-ehdotuksia
- Antiviral Agents 4
- Antiviral agents 4
- COVID-19 4
- COVID-19 (Disease)
- Chemotherapy 4
- Clinical trials 4
- Coronavirus infections 4
- Development 4
- Interferon 4
- Interferon-beta 4
- Nebulizers and Vaporizers 4
- SARS-CoV-2 4
- Treatment 4
- Treatment Outcome 4
- administration & dosage 4
- drug therapy 4
- therapeutic use 4
- Clinical Trials as Topic 2
- Clinical Trials, Phase II as Topic 2
- Drug Delivery Systems 2
- Pneumonia, Viral 2
- Precision Medicine 2
- Prevention 2
- prevention & control 2
-
1
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Julkaistu 2020Hae kokoteksti
Series
Elektroninen Ääni -
2
INFbeta therapy for COVID-19 the new SNG001 drug /
Julkaistu 2020Hae kokoteksti
Series
Elektroninen Ääni -
3
INFbeta therapy for COVID-19 the new SNG001 drug /
Julkaistu 2020Hae kokoteksti
Series
Elektroninen Ääni -
4
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Julkaistu 2020Hae kokoteksti
Series
Elektroninen Ääni
